These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6888190)

  • 1. Dopamine D1 receptors in human parathyroid gland: in vitro and in vivo studies.
    Cross AJ; Ferrier IN; Bloxham CA
    Life Sci; 1983 Aug; 33(8):743-7. PubMed ID: 6888190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors.
    Cross AJ; Crow TJ; Owen F
    Psychopharmacology (Berl); 1981; 74(2):122-4. PubMed ID: 6791218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
    Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptors.
    Cross AJ; Waddington JL; Ross ST
    Life Sci; 1983 Jun; 32(24):2733-40. PubMed ID: 6222234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct demonstration of D1 dopamine receptors in the bovine parathyroid gland using the D1 selective antagonist [125I]-SCH 23982.
    Monsma FJ; Sibley DR
    Synapse; 1989; 3(3):193-9. PubMed ID: 2524116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 105(1-2):171-4. PubMed ID: 6149143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of 3H-cis-flupenthixol binding in rat striatum.
    Murrin LC
    Life Sci; 1983 Nov; 33(22):2179-86. PubMed ID: 6645796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro.
    Hyttel J
    Life Sci; 1981 Feb; 28(5):563-9. PubMed ID: 6111013
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
    Leff SE; Hamblin MW; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):171-83. PubMed ID: 3969066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological differentiation of neuroleptic effect on dopamine D-1 and D-2 receptors.
    Hyttel J; Christensen AV
    J Neural Transm Suppl; 1983; 18():157-64. PubMed ID: 6135740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Neurochem; 1986 Feb; 46(2):413-21. PubMed ID: 3941314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptors of the calf parathyroid gland: identification of a ligand binding subunit with lower apparent molecular weight but similar primary structure to neuronal D1-receptors.
    Niznik HB; Jarvie KR; Brown EM
    Biochemistry; 1989 Aug; 28(17):6925-30. PubMed ID: 2531003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.
    Lal S; Nair NP; Thavundayil JX; Tawar V; Quirion R; Guyda H
    J Neural Transm Gen Sect; 1991; 85(2):157-64. PubMed ID: 1930878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of dopamine D1 receptors in rat striatum.
    Zeng WY; Hyttel J; Murrin LC
    J Neurochem; 1988 Mar; 50(3):862-7. PubMed ID: 2963092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a dopamine- and 3'5'-cyclic adenosine monophosphate-regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid gland.
    Meister B; Askergren J; Tunevall G; Hemmings HC; Greengard P
    J Endocrinol Invest; 1991 Sep; 14(8):655-61. PubMed ID: 1663529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication.
    Cotes PM; Crow TJ; Johnstone EC; Bartlett W; Bourne RC
    Psychol Med; 1978 Nov; 8(4):657-65. PubMed ID: 364517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the dopamine-responsive adenylate cyclase of bovine parathyroid cells and its relationship to parathyroid hormone secretion.
    Attie MF; Brown EM; Gardner DG; Spiegel AM; Aurbach GD
    Endocrinology; 1980 Dec; 107(6):1776-81. PubMed ID: 7428692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kainic acid lesions dissociate [3H] spiperone and [3H]cis-flupenthixol binding sites in rat striatum.
    Cross AJ; Waddington JL
    Eur J Pharmacol; 1981 May; 71(2-3):327-32. PubMed ID: 7250192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.